Navigation Links
Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
Date:8/15/2013

HOUSTON, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics.  Both companies are also countersuing Myriad for violations of the Federal Antitrust Act.

On June 13, 2013, immediately following the United States Supreme Court's 9-0 landmark decision against Myriad in "Association For Molecular Pathology v. Myriad Genetics," Gene By Gene announced its intention to offer fast, accurate and affordable BRCA1/2 testing to the public.

"The Supreme Court was very clear that gene sequences, even when isolated, cannot be patented," said Gene By Gene President Bennett Greenspan. "In light of this ruling we are pleased that we can now offer Americans the benefit of this more affordable test that we have already successfully offered to overseas clients."

Gene By Gene has been providing BRCA1/2 tests to individuals outside the U.S. since 2012. Those tests are processed at the company's Genomic Research Center in Houston, a CLIA-registered lab.  The company has processed various genetic tests – including BRCA1/2 -- for close to a million individuals and organizations globally.

Yesterday Gene By Gene also filed a declaration with the court outlining the details of its BRCA1/2 test, which it will continue to offer to the public.

Greenspan added, "We look forward to a swift resolution of this litigation to level the playing field for test providers, and to enable greater numbers of people to benefit from the genomics revolution."

About Gene By Gene Ltd.

Founded in 2000, Gene By Gene, Ltd. provides reliable DNA testing, focused on ancestry, health, research and paternity, to a wide range of consumer and institutional customers. Gene By Gene provides DNA tests through its Family Tree DNA division, which pioneered the concept of direct-to­consumer (DTC) testing in the field of genetic genealogy more than a decade ago. Gene By Gene is CLIA registered and through its clinical health division offers regulated diagnostic tests. The Research Use Only (RUO) division serves both DTC and institutional clients worldwide. Gene By Gene offers AABB certified relationship tests through its paternity testing division. The privately held company is headquartered in Houston, which is also home to its state-of-the-art Genomics Research Center.

Media Contact:

For Gene By Gene, Ltd.
Kate Croft
Casteel Schoenborn
croft@csirfirm.com
888-609-8351


'/>"/>
SOURCE Gene By Gene, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Court Partially Rejects DOJ "Stay" in Decade-Long Battle for Emergency Contraception Over the Counter
2. Essential Medical Dismisses Patent Case against Masimo and Cercacor
3. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
4. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
5. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
6. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
7. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
8. Broad Patent Protection Granted for iBio Immunomodulator
9. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
10. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
11. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , December 8, 2016 ... on the research, distribution, and marketing of pharmaceutical drug ... by patent protection and expiration. Additionally, these firms typically ... sector as a whole. Up for review this morning ... Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), Pernix ...
(Date:12/8/2016)... , Dec. 8, 2016 Spotlight ... advancing technologies designed to address rare, emerging and ... Chitra Edwin , Ph.D., RAC, as Senior Vice ... will provide leadership for all U.S. and international ... preparation of regulatory submissions, serving as the primary ...
(Date:12/7/2016)... "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by PNS ... in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially available ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... on Lantus expired in 2014. Lantus is the brand name for ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Vida ... raised an $18M Series B led by Canvas Ventures . Other investors include ... to scale its mobile platform to serve more consumers who are managing chronic ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... The Compretta ... commercial and residential clients in and around the Hancock County area, is announcing the ... Hancock County Food Pantry. , The Hancock County Food Pantry has worked for more ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in ... MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that meets the needs ... where and when it’s needed. , A 2’ x 4’ model features ...
Breaking Medicine News(10 mins):